5941153bb7
Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
6.7 KiB
6.7 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | CONTROLLED SUBSTANCES-OPIOIDS | Amends the Illinois Controlled Substances Act. Provides that, notwithstanding any other provision of law, a prescription for a substance in Schedule II, III, IV, or V must be sent electronically, in accordance with provisions regarding the Prescription Monitoring Program. Effective immediately. | us/states/il | Illinois General Assembly | 102nd | HB 3596 | Illinois HB 3596 (102nd) |
|
enacted |
|
4 | 50 | 2 | 2021-02-19 | 2021-08-20 | openstates | ocd-bill/51268020-9926-4d99-b6db-234d6ca65498 | https://ilga.gov/legislation/BillStatus.asp?DocNum=3596&GAID=16&DocTypeID=HB&LegId=132636&SessionID=110&GA=102 | c63dd66416db4acb3f41dea69d33a301b98657efb3324e776f7c5ff709adb1bf | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Illinois HB 3596 (102nd) — CONTROLLED SUBSTANCES-OPIOIDS
Amends the Illinois Controlled Substances Act. Provides that, notwithstanding any other provision of law, a prescription for a substance in Schedule II, III, IV, or V must be sent electronically, in accordance with provisions regarding the Prescription Monitoring Program. Effective immediately.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- Introduced (filed) — source
- Engrossed (committee substitute) — source
- House Amendment 001 (committee substitute) — source
- Enrolled (enrolled) — source
Votes
- Third Reading — 59–0 (pass) · upper
- Third Reading — 111–0 (pass) · lower
Sponsors
- Dagmara Avelar — primary (person)
- Emil Jones, III — primary (person)
- Aaron M. Ortiz — cosponsor (person)
- Angelica Guerrero-Cuellar — cosponsor (person)
- Anthony DeLuca — cosponsor (person)
- Barbara Hernandez — cosponsor (person)
- Christopher Belt — cosponsor (person)
- Delia C. Ramirez — cosponsor (person)
- Edgar Gonzalez, Jr. — cosponsor (person)
- Elizabeth Hernandez — cosponsor (person)
- Emanuel Chris Welch — cosponsor (person)
- Eva-Dina Delgado — cosponsor (person)
- Jaime M. Andrade, Jr. — cosponsor (person)
- Joyce Mason — cosponsor (person)
- Justin Slaughter — cosponsor (person)
- Kathleen Willis — cosponsor (person)
- La Shawn K. Ford — cosponsor (person)
- Mary E. Flowers — cosponsor (person)
- Stephanie A. Kifowit — cosponsor (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2021-02-19 Filed with the Clerk by Rep. Dagmara Avelar
filing - 2021-02-22 First Reading
reading-1 - 2021-02-22 Referred to Rules Committee
referral-committee - 2021-03-16 Assigned to Prescription Drug Affordability & Accessibility Committee
referral-committee - 2021-03-18 Added Co-Sponsor Rep. Aaron M. Ortiz
- 2021-03-18 Added Co-Sponsor Rep. Delia C. Ramirez
- 2021-03-18 Added Co-Sponsor Rep. Edgar Gonzalez, Jr.
- 2021-03-18 Added Co-Sponsor Rep. Jaime M. Andrade, Jr.
- 2021-03-18 Added Co-Sponsor Rep. Angelica Guerrero-Cuellar
- 2021-03-18 Added Co-Sponsor Rep. Eva-Dina Delgado
- 2021-03-18 Added Co-Sponsor Rep. Elizabeth Hernandez
- 2021-03-18 Added Co-Sponsor Rep. Barbara Hernandez
- 2021-03-25 Added Co-Sponsor Rep. Joyce Mason
- 2021-03-25 Do Pass / Short Debate Prescription Drug Affordability & Accessibility Committee; 018-000-000
committee-passage - 2021-04-08 Placed on Calendar 2nd Reading - Short Debate
- 2021-04-13 Second Reading - Short Debate
reading-2 - 2021-04-13 Placed on Calendar Order of 3rd Reading - Short Debate
- 2021-04-20 House Floor Amendment No. 1 Filed with Clerk by Rep. Dagmara Avelar
amendment-introduction - 2021-04-20 House Floor Amendment No. 1 Referred to Rules Committee
referral-committee - 2021-04-20 Added Co-Sponsor Rep. Emanuel Chris Welch
- 2021-04-20 Added Co-Sponsor Rep. Stephanie A. Kifowit
- 2021-04-20 Added Co-Sponsor Rep. Mary E. Flowers
- 2021-04-21 House Floor Amendment No. 1 Rules Refers to Prescription Drug Affordability & Accessibility Committee
- 2021-04-21 Added Co-Sponsor Rep. Justin Slaughter
- 2021-04-21 Added Co-Sponsor Rep. Kathleen Willis
- 2021-04-22 House Floor Amendment No. 1 Recommends Be Adopted Prescription Drug Affordability & Accessibility Committee; 017-002-000
committee-passage-favorable - 2021-04-22 Added Co-Sponsor Rep. Anthony DeLuca
- 2021-04-23 Recalled to Second Reading - Short Debate
reading-2 - 2021-04-23 House Floor Amendment No. 1 Adopted
amendment-passage - 2021-04-23 Placed on Calendar Order of 3rd Reading - Short Debate
- 2021-04-23 Third Reading - Short Debate - Passed 111-000-000
passage, reading-3 - 2021-04-23 Added Chief Co-Sponsor Rep. La Shawn K. Ford
- 2021-04-27 Arrive in Senate
introduction - 2021-04-27 Placed on Calendar Order of First Reading
reading-1 - 2021-04-27 Chief Senate Sponsor Sen. Emil Jones, III
- 2021-04-27 First Reading
reading-1 - 2021-04-27 Referred to Assignments
referral-committee - 2021-05-10 Assigned to Licensed Activities
referral-committee - 2021-05-19 Do Pass Licensed Activities; 007-000-000
committee-passage - 2021-05-19 Placed on Calendar Order of 2nd Reading May 20, 2021
- 2021-05-20 Added as Alternate Chief Co-Sponsor Sen. Christopher Belt
- 2021-05-24 Second Reading
reading-2 - 2021-05-24 Placed on Calendar Order of 3rd Reading May 25, 2021
- 2021-05-27 Placed on Calendar Order of 3rd Reading ** May 28, 2021
- 2021-05-29 Third Reading - Passed; 059-000-000
passage, reading-3 - 2021-05-29 Passed Both Houses
- 2021-06-25 Sent to the Governor
executive-receipt - 2021-08-20 Governor Approved
executive-signature - 2021-08-20 Effective Date January 1, 2023
- 2021-08-20 Public Act . . . . . . . . . 102-0490
became-law
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/51268020-9926-4d99-b6db-234d6ca65498. Confidence: reported (aggregated from official Illinois legislature records).